Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Equity (Details Narrative)

Equity (Details Narrative) - USD ($)								1 Months Ended	3 Months Ended
Equity (Details Narrative) - USD ($)	Mar. 30, 2017	Mar. 23, 2017	Mar. 22, 2017	Feb. 08, 2017	Jan. 25, 2017	Jan. 06, 2017	Dec. 22, 2016	Feb. 28, 2017	Mar. 31, 2017	Mar. 31, 2016	Oct. 31, 2014
Gross proceeds from equity offerings									$ 12,200,000
Proceeds from issuance of common stock									10,701,000
Proceeds from issuance or sale of equity							$ 1,900,000		$ 1,220,000
Exchanged Notes [Member]
Debt instrument, interest rate, stated percentage		1.01%
Exchanged Notes [Member]
Debt instrument, percentage of face amount secured		55.00%
Debt instrument, percentage of face amount at maturity		125.00%
Investor [Member] \| Exchanged Convertible Note [Member]
Number of common stock issued, shares	1,730,534
Debt instrument principal amount	$ 4,200,000
Debt convertible percentage of common stock	80.00%
Investor [Member] \| Exchanged Non-Convertible Note [Member] \| April 18, 2017 [Member]
Number of common stock issued, shares									1,610,000
Commo stock price, per share									$ 2.20
Debt instrument principal amount									$ 3,550,000
RedPath Equityholder Representative [Member] \| Termination Agreement [Member]
Warrants to purchase shares of common stock			100,000
Common stock purchase price per share			$ 4.69
Fair value of warrants issued			$ 193,037
Warrant term			5 years
Secured Promissory Note [Member] \| RedPath Integrated Pathology, Inc [Member]
Debt instrument principal amount											$ 9,340,000
Secured Promissory Note [Member] \| RedPath Integrated Pathology, Inc [Member] \| Investor [Member]
Debt instrument principal amount											$ 8,870,000
Senior Secured Convertible Note [Member] \| Exchanged Convertible Note [Member]
Debt instrument principal amount		$ 5,320,000
Senior Secured Non-Convertible Note [Member] \| Exchanged Non-Convertible Note [Member]
Debt instrument principal amount		3,550,000
Senior Secured Non-Convertible Note [Member] \| Exchanged Notes [Member]
Debt instrument principal amount		$ 8,870,000
Employee Severance [Member]
Payments for restructuring								$ 1,000,000
Second Registered Direct Offering [Member]
Number of common stock issued, shares						630,000
Commo stock price, per share						$ 6.81
Proceeds from issuance of common stock						$ 4,200,000
Third Registered Direct Offering [Member]
Number of common stock issued, shares					855,000
Fair value of warrants issued					$ 1,668,290
Third Registered Direct Offering [Member] \| Employee Severance [Member]
Payments for restructuring					$ 1,000,000
Third Registered Direct Offering [Member] \| Private Placement [Member]
Warrants to purchase shares of common stock					855,000
Common stock purchase price per share					$ 4.69
Proceeds from issuance or sale of equity					$ 4,000,000
Confidentially Marketed Public Offering (CMPO) [Member]
Number of common stock issued, shares				1,200,000
Commo stock price, per share				$ 3.00
Option to purchase, overallotment option, percentage				9.00%